Data as of Apr 17
| +0.171 / +0.75%|
The 10 analysts offering 12-month price forecasts for Mesoblast Ltd have a median target of 36.92, with a high estimate of 63.19 and a low estimate of 15.68. The median estimate represents a +61.76% increase from the last price of 22.82.
The current consensus among 10 polled investment analysts is to Buy stock in Mesoblast Ltd. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.